Literature DB >> 26036158

Treatment for erythropoietic protoporphyria.

J G Langendonk1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26036158     DOI： 10.1111/bjd.13769

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

Review 1.  Identification of FECH gene multiple variations in two Chinese patients with erythropoietic protoporphyria and a review.

Authors:  Zhang-Biao Long; Yong-Wei Wang; Chen Yang; Gang Liu; Ya-Li Du; Guang-Jun Nie; Yan-Zhong Chang; Bing Han
Journal:  J Zhejiang Univ Sci B       Date:  2016 Oct.       Impact factor: 3.066

2.  Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria.

Authors:  Charles J Parker; Robert J Desnick; Montgomery D Bissel; Joseph R Bloomer; Ashwani Singal; Laurent Gouya; Herve Puy; Karl E Anderson; Manisha Balwani; John D Phillips
Journal:  Mol Genet Metab       Date:  2019-07-31       Impact factor: 4.797

3.  The Patient Perspective: A Matter of Minutes.

Authors:  Rocco Falchetto
Journal:  Patient       Date:  2020-02       Impact factor: 3.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.